These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 10967757

  • 1. Recent developments in the chemotherapy of advanced esophageal cancer.
    Edelman MJ.
    Chest Surg Clin N Am; 2000 Aug; 10(3):561-7. PubMed ID: 10967757
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel in the treatment of esophageal cancer.
    Weiner LM.
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
    [Abstract] [Full Text] [Related]

  • 3. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, Kelsen DP.
    Cancer J; 2000 Feb; 6(5):316-23. PubMed ID: 11079171
    [Abstract] [Full Text] [Related]

  • 4. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P, Stoll P, Wannenmacher M, Zierhut D.
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J, Haensgen G.
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ, Cho SH, Yoon JY, Hwang JE, Bae WK, Shim HJ, Chung IJ.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [Abstract] [Full Text] [Related]

  • 7. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF.
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [Abstract] [Full Text] [Related]

  • 8. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).
    Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, Ando N, Tanaka O, Shinoda M, Yamana H, Ishikura S.
    Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Yamaguchi K, Nakagawa S, Yabusaki H, Nashimoto A.
    Anticancer Res; 2007 Oct; 27(5B):3535-9. PubMed ID: 17972514
    [Abstract] [Full Text] [Related]

  • 11. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
    El Nakadi I, Van Laethem JL, Houben JJ, Gay F, Closset J, Van Houtte P, Danhier S, Limbosch JM, Lambilliotte JP, Gelin M.
    World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S, Parshad R, Kapoor A, Gupta SD, Kumar A, Chattophadyay TK.
    Indian J Cancer; 2004 Jan; 41(1):3-7. PubMed ID: 15105572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quality of life in cancer patients treated by chemotherapy.
    Scieszka M, Zielinski M, Machalski M, Herman ZS.
    Neoplasma; 2000 Feb; 47(6):396-9. PubMed ID: 11263865
    [Abstract] [Full Text] [Related]

  • 17. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in antioxidant defense status in response to cisplatin and 5-FU in esophageal carcinoma.
    Kaur T, Khanduja KL, Gupta R, Gupta NM, Vaiphei K.
    Dis Esophagus; 2008 Oct; 21(2):103-7. PubMed ID: 18269643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.